08.07.15Back to News

Paradigm Expands Access to PCDX Personalized Medicine Service by Signing Contract with Three Rivers Provider Network

 

Paradigm Cancer Diagnostic (PCDxTM) test now accessible to an additional 15 Million covered lives in US

[Ann Arbor, MI and Phoenix, AZ, August 7, 2015]– Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing cancer testing for patients with cancer, has signed an agreement with health insurer Three Rivers Provider Network, Inc., one of the largest and fastest-growing preferred provider (“PPO”) networks in the U.S. Under the terms of the agreement, Paradigm’s Cancer Diagnostic Test (PCDx) will be available to more than 15 million US members of Three Rivers Provider Network.

PCDx™ is a Next-Generation Sequencing (NGS) based diagnostic test that is designed to provide physicians and patients with information to allow a more targeted, personalized approach to cancer treatment by identifying the underlying genomic and proteomic alterations of a patient’s tumor’s DNA, RNA & protein.

Dr. Robert Penny, MD, PhD, CEO of Paradigm, noted, “We continue to make strong progress with provider networks to ensure our best-in-class NGS test is available to the millions of Americans who are suffering with cancer. With this contract, millions of patients and their treating clinicians will have access to our leading oncology testing service and make possible more informed and individually tailored treatment strategies.”

About PARADIGM

Paradigm is a molecular information corporation established to bring cutting-edge diagnostics to cancer patients and industry by providing information about the genomic makeup of the patient’s cancer and potential therapies based on the specific characterization of the patient’s tumor that can impact the patient’s course of treatment. Paradigm’s Next-Generation Sequencing based diagnostic test PCDx provides oncologists and patients with more precise information about the specific cancer pathways in the patient and associations between the pathways and the specific drugs available that can affect the cancer to allow for more effective decision-making. The test is driven by supporting data and literature and provides more choices for patient care than currently available on the market. For more information visit http://www.paradigmdx.com.

 

About THREE RIVERS PROVIDER NETWORK

Three Rivers Provider Network was founded in 1996 as a company that was contracted to provide services for several major auto clients. At that time, its clients needed to access a network that would grant PPO-type discounts without incurring balance billing risks for their members. Over time, given superior results and high levels of satisfaction of service, TRPN was prompted by other companies that focused on group health and workers’ compensation to perform similar type services for them. TRPN contracts were uniquely designed for group health, workers’ compensation and auto liability claims expanding existing coverage and significantly reducing out-of-network expense.

Since that time, TRPN has evolved into the largest and fastest-growing proprietary PPO network in the U.S. The TRPN network is now comprised of more than 550,000 total providers, including more than 5,000 hospitals and 70,000 ancillary facilities. Through its clients, approximately 15 million lives now have access to the TRPN PPO network.

 

Start getting better results, faster.

Order PCDx